Venus Concept

VERO

Börsenwert 2,12 Mio. $

TORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) announced today its voluntarily decision to delist its common stock from the NASDAQ Capital Market (“Nasdaq”) and deregister its common stock with the Securities and Exchange Commission (the “SEC”).

As of Jan. 20, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Venus Concept Inc. (NASDAQ: VERO) stock skyrocketed over 500% on Friday.

Venus Concept Inc. ( VERO ) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants Rajiv Kanishka De Silva - CEO & Director Domenic Penna - Executive VP & CFO Presentation Operator Good day, ladies and gentlemen, and welcome to the Third Quarter 2025 Earnings Conference Call for Venus Concept Inc. [Operator Instructions] Please note that this conference call is being recorded and that the recording will be available on the company's website for replay. Before we begin, I would like to remind everyone that our remarks and responses to your questions may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated including those identified in the Risk Factors section of our most recent annual report on Form 10-K filed with the Securities and Exchange Commission.

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2025.

Reduction of outstanding debt by Madryn Asset Management continues to improve the Company's financial position Reduction of outstanding debt by Madryn Asset Management continues to improve the Company's financial position

TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2025 financial results will be released before the market opens on Thursday, November 13, 2025.

Growing popularity of advanced cosmetic technologies, social media influence, and increasing aesthetic consciousness are fueling robust growth in the global cellulite treatment market. Growing popularity of advanced cosmetic technologies, social media influence, and increasing aesthetic consciousness are fueling robust growth in the global cellulite treatment market.

Venus Concept Inc. (NASDAQ:VERO ) Q2 2025 Earnings Conference Call August 14, 2025 5:00 PM ET Company Participants Domenic Della Penna - Executive VP & CFO Rajiv Kanishka Liyanaarchchie De Silva - CEO & Director Operator Good day, ladies and gentlemen, and welcome to the Second Quarter 2025 Earnings Conference Call for Venus Concept Inc. [Operator Instructions] Please note that this conference call is being recorded and that the recording will be available on the company's website for replay. Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward- looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including those identified in the Risk Factors section of our most recent annual report on Form 10-K filed with the Securities and Exchange Commission.

TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2025.